These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 26602979)
1. Endotoxemia Engages the RhoA Kinase Pathway to Impair Cardiac Function By Altering Cytoskeleton, Mitochondrial Fission, and Autophagy. Preau S; Delguste F; Yu Y; Remy-Jouet I; Richard V; Saulnier F; Boulanger E; Neviere R Antioxid Redox Signal; 2016 Apr; 24(10):529-42. PubMed ID: 26602979 [TBL] [Abstract][Full Text] [Related]
2. The Rho kinase inhibitor, fasudil, ameliorates diabetes-induced cardiac dysfunction by improving calcium clearance and actin remodeling. Lai D; Gao J; Bi X; He H; Shi X; Weng S; Chen Y; Yang Y; Ye Y; Fu G J Mol Med (Berl); 2017 Feb; 95(2):155-165. PubMed ID: 27576917 [TBL] [Abstract][Full Text] [Related]
3. Advanced glycation end products receptor RAGE controls myocardial dysfunction and oxidative stress in high-fat fed mice by sustaining mitochondrial dynamics and autophagy-lysosome pathway. Yu Y; Wang L; Delguste F; Durand A; Guilbaud A; Rousselin C; Schmidt AM; Tessier F; Boulanger E; Neviere R Free Radic Biol Med; 2017 Nov; 112():397-410. PubMed ID: 28826719 [TBL] [Abstract][Full Text] [Related]
4. ROCK induced inflammation of the microcirculation during endotoxemia mediated by nitric oxide synthase. McGown CC; Brown NJ; Hellewell PG; Brookes ZL Microvasc Res; 2011 May; 81(3):281-8. PubMed ID: 21354186 [TBL] [Abstract][Full Text] [Related]
5. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses isoproterenol-induced heart failure in rats via JNK and ERK1/2 pathways. Wang N; Guan P; Zhang JP; Li YQ; Chang YZ; Shi ZH; Wang FY; Chu L J Cell Biochem; 2011 Jul; 112(7):1920-9. PubMed ID: 21433064 [TBL] [Abstract][Full Text] [Related]
6. Fasudil, a Rho-kinase inhibitor, attenuates lipopolysaccharide-induced vascular hyperpermeability and colonic muscle relaxation in guinea pigs. Suzuki K; Nemoto K; Ninomiya N; Kuno M; Kubota M; Yokota H J Surg Res; 2012 Nov; 178(1):352-7. PubMed ID: 22487385 [TBL] [Abstract][Full Text] [Related]
7. Inflammatory lung injury is associated with endothelial cell mitochondrial fission and requires the nitration of RhoA and cytoskeletal remodeling. Pokharel MD; Fu P; Garcia-Flores A; Yegambaram M; Lu Q; Sun X; Unwalla H; Aggarwal S; Fineman JR; Wang T; Black SM Free Radic Biol Med; 2024 Aug; 221():125-135. PubMed ID: 38734269 [TBL] [Abstract][Full Text] [Related]
8. RhoA regulates Drp1 mediated mitochondrial fission through ROCK to protect cardiomyocytes. Brand CS; Tan VP; Brown JH; Miyamoto S Cell Signal; 2018 Oct; 50():48-57. PubMed ID: 29953931 [TBL] [Abstract][Full Text] [Related]
9. Fasudil attenuates lipopolysaccharide-induced acute lung injury in mice through the Rho/Rho kinase pathway. Li Y; Wu Y; Wang Z; Zhang XH; Wu WK Med Sci Monit; 2010 Apr; 16(4):BR112-118. PubMed ID: 20357711 [TBL] [Abstract][Full Text] [Related]
10. Permissive role of AMPK and autophagy in adiponectin deficiency-accentuated myocardial injury and inflammation in endotoxemia. Ren J; Xu X; Wang Q; Ren SY; Dong M; Zhang Y J Mol Cell Cardiol; 2016 Apr; 93():18-31. PubMed ID: 26906634 [TBL] [Abstract][Full Text] [Related]
11. Chronic Rho-kinase inhibition improves left ventricular contractile dysfunction in early type-1 diabetes by increasing myosin cross-bridge extension. Waddingham MT; Edgley AJ; Astolfo A; Inagaki T; Fujii Y; Du CK; Zhan DY; Tsuchimochi H; Yagi N; Kelly DJ; Shirai M; Pearson JT Cardiovasc Diabetol; 2015 Jul; 14():92. PubMed ID: 26194354 [TBL] [Abstract][Full Text] [Related]
16. Pretreatment with Rho-kinase inhibitor ameliorates lethal endotoxemia-induced liver injury by improving mitochondrial function. Ding R; Han J; Zhao D; Hu Z; Ma X Int Immunopharmacol; 2016 Nov; 40():125-130. PubMed ID: 27588912 [TBL] [Abstract][Full Text] [Related]
17. Fasudil ameliorates the ischemia/reperfusion oxidative injury in rat hearts through suppression of myosin regulatory light chain/NADPH oxidase 2 pathway. Zhang YS; Tang LJ; Tu H; Wang SJ; Liu B; Zhang XJ; Li NS; Luo XJ; Peng J Eur J Pharmacol; 2018 Mar; 822():1-12. PubMed ID: 29337194 [TBL] [Abstract][Full Text] [Related]
18. Rho kinase inhibition by fasudil suppresses lipopolysaccharide-induced apoptosis of rat pulmonary microvascular endothelial cells via JNK and p38 MAPK pathway. Liu H; Chen X; Han Y; Li C; Chen P; Su S; Zhang Y; Pan Z Biomed Pharmacother; 2014 Apr; 68(3):267-75. PubMed ID: 24406296 [TBL] [Abstract][Full Text] [Related]
19. Acute inhibition of Rho-kinase improves cardiac contractile function in streptozotocin-diabetic rats. Lin G; Craig GP; Zhang L; Yuen VG; Allard M; McNeill JH; MacLeod KM Cardiovasc Res; 2007 Jul; 75(1):51-8. PubMed ID: 17428455 [TBL] [Abstract][Full Text] [Related]
20. Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage. Arita R; Hata Y; Nakao S; Kita T; Miura M; Kawahara S; Zandi S; Almulki L; Tayyari F; Shimokawa H; Hafezi-Moghadam A; Ishibashi T Diabetes; 2009 Jan; 58(1):215-26. PubMed ID: 18840783 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]